- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Fatty Acids, Nonesterified in Austria
Total 155 results
-
Medical University of ViennaCompletedGlomerular Filtration Rate | Fatty Acids, Nonesterified | Renal Circulation | Renal Plasma FlowAustria
-
Reneo Pharma LtdCompletedFatty Acid Oxidation DisorderUnited States, Spain, France, Austria, Poland, Belgium, Czechia, Denmark, Hungary, Italy, United Kingdom
-
Phenex Pharmaceuticals AGMedical University of ViennaCompletedNon Alcoholic Fatty Liver DiseaseAustria
-
Hoffmann-La RocheCompletedFatty Liver, Non-alcoholic Fatty Liver Disease, NAFLDGermany, Austria
-
Dr. Falk Pharma GmbHRecruiting
-
Medical University of ViennaRecruiting
-
Medical University of ViennaState Government of Vienna, Austria (Medizinisch-Wissenschaftlicher Fonds...CompletedNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisAustria
-
Novo Nordisk A/SRecruitingHealthy Volunteers (Non-alcoholic Steatohepatitis)Austria
-
Prof. Michael Trauner, MDWiener Wissenschafts-, Forschungs- und TechnologiefondsUnknownNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisAustria
-
Medical University of ViennaRecruitingBariatric Surgery Candidate | NASH - Nonalcoholic Steatohepatitis | Intestinal PermeabilityAustria
-
RWTH Aachen UniversityCompletedNASH - Nonalcoholic SteatohepatitisSweden, Austria, Germany
-
Inipharm Australia Pty LtdRecruitingNon-alcoholic SteatohepatitisAustralia
-
Eccanga Pty LtdSyneos HealthRecruiting
-
Altimmune, Inc.Completed
-
Dr. Andreas KammerlanderUnknownHeart Failure | Coronary Disease | NAFLD | Valvular DiseaseAustria
-
Dongguan HEC Biopharmaceutical R&D Co., Ltd.CompletedThe Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy SubjectsNon-alcoholic SteatohepatitisAustralia
-
Syneos HealthCompleted
-
JD Bioscience Inc.Novotech (Australia) Pty LimitedEnrolling by invitation
-
Sunshine Lake Pharma Co., Ltd.CompletedNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisAustralia
-
NGM Biopharmaceuticals, IncCompleted
-
Enyo PharmaCompletedHealthy | NASH - Nonalcoholic SteatohepatitisAustralia
-
Bird Rock Bio, Inc.Perspectum; ProSciento, Inc.CompletedNAFLDUnited States, Australia, Canada
-
VASCage GmbHMedical University Innsbruck; Tirol Kiniken GmbHCompletedCardiovascular Diseases | Vascular Diseases | Hypertension | Obesity | Overweight | Sleep Disorder | Atherosclerosis | Sleep | Headache | Vascular Stiffness | Cardiovascular Risk Factor | Non-Alcoholic Fatty Liver Disease | Life Style | Cardiovascular PathologyAustria
-
Blade TherapeuticsCompletedNASH - Nonalcoholic Steatohepatitis | Chronic Liver DiseaseAustralia
-
Altimmune, Inc.CompletedNASH - Nonalcoholic SteatohepatitisAustralia
-
LISCure BiosciencesCompletedRheumatoid Arthritis | Non-Alcoholic SteatohepatitisAustralia
-
Altimmune, Inc.RecruitingNon-Alcoholic Steatohepatitis (NASH)Australia, United States, Puerto Rico
-
University of Texas at AustinRecruitingMetabolic Syndrome | NAFLD | Pre-diabetes | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Bristol-Myers SquibbTerminatedNonalcoholic Fatty Liver DiseaseUnited States
-
Green BeatMedical University of GrazCompletedInflammation | Oxidative Stress | AcidosisAustria
-
Rivus Pharmaceuticals, Inc.RecruitingFatty Liver | Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Medical University of ViennaCompletedMetabolic Acidosis | Hyperkalaemia Requiring Postoperative DialysisAustria
-
Austrian Breast & Colorectal Cancer Study GroupMerck Gesellschaft mbH, AustriaTerminatedColorectal Cancer | SteatohepatitisAustria
-
Sagimet Biosciences Inc.CompletedNon-Alcoholic Fatty Liver DiseaseChina, United States
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompletedNonalcoholic Steatohepatitis (NASH)United States, Australia, Puerto Rico
-
Second GenomeTerminatedNonalcoholic SteatohepatitisUnited States
-
GlaxoSmithKlineRecruitingNon-alcoholic Fatty Liver DiseaseUnited States
-
Corcept TherapeuticsRecruitingNonalcoholic Steatohepatitis (NASH)United States
-
Corcept TherapeuticsActive, not recruitingNonalcoholic Steatohepatitis (NASH)United States
-
89bio, Inc.ProSciento, Inc.Completed
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Israel, Taiwan, Canada, Australia, Poland
-
Altimmune, Inc.CompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
Sciwind Biosciences APAC CO Pty. Ltd.Hangzhou Sciwind Biosciences Co., Ltd.CompletedObesity | Type 2 Diabetes Mellitus | Nonalcoholic SteatohepatitisAustralia
-
Merck Sharp & Dohme LLCCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Canada, France, Israel, Italy, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
GlaxoSmithKlineRecruitingNonalcoholic Fatty Liver DiseaseUnited States, Australia, Italy, Japan, Spain, Belgium, Argentina, Canada, United Kingdom, Korea, Republic of, France, Greece, India, Mexico, Puerto Rico, Turkey, Panama
-
Altimmune, Inc.CompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
AstraZenecaRecruitingNon-alcoholic Steatohepatitis (NASH)Austria, Germany, Japan, Sweden
-
Akero Therapeutics, IncRecruitingNASH/MASH | NAFLD/MASLDUnited States, Canada, Puerto Rico, Australia, India, Israel, Switzerland, United Kingdom
-
Corcept TherapeuticsTerminatedNonalcoholic Steatohepatitis (NASH)United States
-
Axcella Health, IncCompleted